For the Inventor, By the Inventor

Enter assignee name

Miami, FL, United States of America

Demerx, Inc.

USPTO Granted Patents = 37

% Expired Patents = 10.8

EPO Patents = 5

Trademarks = 3

Forward Citations = 266

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Robert M Moriarty (17 out of 80 patents)

Deborah C Mash (17 out of 24 patents)

Richard D Gless (13 out of 28 patents)

4. Emeline Maillet (5 out of 7 patents)

5. Lawrence Friedhoff (5 out of 9 patents)

6. Holger Weis (3 out of 5 patents)

7. William C Schinzer (2 out of 3 patents)

8. Mark Kinch (1 out of 1 patent)

9. Richard D Gless, Jr (1 out of 1 patent)

10. Simon Mbua Ngale Efange (1 out of 1 patent)

11. Philip Sigel (1 out of 1 patent)

12. Pascal Goldschmidt (1 out of 1 patent)

37 patents: Sort by Forward Citations

1. 12653831 - Methods for the non-toxic treatment for opioid drug withdrawal combining noribogaine and cannabinoids (2026-06-16),

2. 11260059 - Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids (2022-03-01),

3. 11197866 - Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids (2021-12-14),

4. 11077118 - Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake (2021-08-03),

5. 9744174 - Method for noribogaine treatment in patients on methadone (2017-08-29),

6. 9617274 - Synthetic noribogaine (2017-04-11),

7. 9617265 - Noribogaine salt ansolvates (2017-04-11),

8. 9592239 - Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake (2017-03-14),

9. 9591978 - Methods and compositions for pre-screening patients for treatment with noribogaine (2017-03-14),

10. 9586954 - N-substituted noribogaine prodrugs (2017-03-07),

11. 9561233 - Use of ibogaine for the treatment of pain (2017-02-07),

12. 9561232 - Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use (2017-02-07),

13. 9550789 - Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them (2017-01-24),

14. 9549935 - Methods and compositions for treating migraines using noribogaine (2017-01-24),

15. 9469649 - Synthetic voacangine (2016-10-18),

DEMERX, INC. is a technology company specializing in innovative software solutions for businesses. With a focus on driving digital transformation, DEMERX offers a wide range of products and services to help organizations streamline their operations, enhance productivity, and improve overall efficiency. Through its cutting-edge technologies and experienced team, DEMERX is dedicated to delivering tailor-made solutions that meet the unique needs of each client. Visit our website to learn more and explore our offerings.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

37 Patents

#19 in Miami, FL

#215 in Florida

#9,234 in US

#18,222 in the World

Miami, FL, United States of America

Demerx, Inc.

Forward Citations = 266

12 inventors:

Robert M Moriarty (17 out of 80 patents)

Deborah C Mash (17 out of 24 patents)

Richard D Gless (13 out of 28 patents)

4. Emeline Maillet (5 out of 7 patents)

5. Lawrence Friedhoff (5 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…